Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1729829 LONDON, X0
Back to XERS Full portfolio

Position in XERS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$22,918,492
-$945,173 QoQ
Shares Held
2,893,749
-29.7% QoQ
Ownership
1.59%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#8
of 240 holders
Holding Since
Dec 2021
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $592,833,307 across 20 Drug Manufacturers - Specialty & Generic names. XERS ranks #6 (3.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 2,279,333 $163,792,869
2 UTHR
UNITED THERAPEUTICS Corp
 233,639 $126,592,619
3 VTRS
Viatris Inc
 6,180,223 $98,141,941
4 SUPN
Supernus Pharmaceuticals, Inc.
 922,166 $42,889,940
5 TAK
Takeda Pharmaceutical Co Ltd
 2,207,432 $35,385,134
6 XERS
Xeris Biopharma Holdings, Inc.
This page 		2,893,749 $22,918,492
7 KNSA
Kiniksa Pharmaceuticals International, plc
 304,080 $19,445,916
8 ANIP
Ani Pharmaceuticals Inc
 192,945 $15,971,987

All Filings in XERS

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $22,918,492 2,893,749
2026-03-31 $23,863,665 4,114,425
2025-12-31 $27,460,846 3,498,197
2025-09-30 $26,657,148 3,274,834
2025-06-30 $14,429,230 3,089,771
2025-03-31 $10,126,760 1,844,583
2024-12-31 $1,558,071 459,608
2024-09-30 $688,477 241,571
2024-06-30 $53,781 23,903
2024-03-31 $394,622 178,562
2023-09-30 $100,222 53,883
2022-06-30 $302,653 196,528
2022-03-31 $244,792 95,622
2021-12-31 $356,367 121,627